Role of CD138, CD56, and light chain immunohistochemistry in suspected and diagnosed plasma cell myeloma: A prospective study.

Dass, Jasmita; Arava, Sudheer; Mishra, Pravas Chandra; Dinda, Amit Kumar; Pati, Hara Prasad

Dass, Jasmita; Arava, Sudheer; Mishra, Pravas Chandra; Dinda, Amit Kumar; Pati, Hara Prasad.

Afiliação

Dass J; Department of Hematology, Sir Ganga Ram Hospital, New Delhi, India.
Arava S; Department of Pathology, All India Institute of Medical Sciences, New Delhi, India.
Mishra PC; Department of Hematology, All India Institute of Medical Sciences, New Delhi, India.
Dinda AK; Department of Pathology, All India Institute of Medical Sciences, New Delhi, India.
Pati HP; Department of Hematology, All India Institute of Medical Sciences, New Delhi, India.

South Asian J Cancer ; 8(1): 60-64, 2019.

Article em En | MEDLINE | ID: mdl-30766858

Palavras-chave

CD138; CD56; lytic lesions; myeloma; plasma cell percentage; reactive plasmacytosis; suspected myeloma

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Guideline / Observational_studies Idioma: En Revista: South Asian J Cancer Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Índia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google